SNRK Tames MTOR Against Metabolic Dysfunction-associated Steatotic Liver Disease

Overview

Journal Mol Ther

Publisher Cell Press

Specialties Molecular Biology
Pharmacology

Date 2024 Dec 27

PMID 39729984

Authors

Nicola Brunetti-Pierri

Lisa Bewersdorf

Pavel Strnad

Affiliations

Soon will be listed here.

References

Lee Y, Noon L, Akat K, Ybanez M, Lee T, Berres M . Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Nat Commun. 2018; 9(1):4962. PMC: 6251897. DOI: 10.1038/s41467-018-07338-z. View

Rinella M, Lazarus J, Ratziu V, Francque S, Sanyal A, Kanwal F . A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023; 79(6):1542-1556. DOI: 10.1016/j.jhep.2023.06.003. View

Allaire M, Rautou P, Codogno P, Lotersztajn S . Autophagy in liver diseases: Time for translation?. J Hepatol. 2019; 70(5):985-998. DOI: 10.1016/j.jhep.2019.01.026. View

Li J, An R, Lai S, Li L, Liu S, Xu H . Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue. Mol Metab. 2019; 28:26-35. PMC: 6822176. DOI: 10.1016/j.molmet.2019.07.009. View

Liu G, Sabatini D . mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020; 21(4):183-203. PMC: 7102936. DOI: 10.1038/s41580-019-0199-y. View

Becker W, Heukelbach J, Kentrup H, Joost H . Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine/threonine kinases. Eur J Biochem. 1996; 235(3):736-43. DOI: 10.1111/j.1432-1033.1996.00736.x. View

Lin S, Qiu X, Fu X, Zhang S, Tang C, Kuang J . SNRK modulates mTOR-autophagy pathway for liver lipid homeostasis in MAFLD. Mol Ther. 2024; 33(1):279-296. PMC: 11764968. DOI: 10.1016/j.ymthe.2024.11.016. View

Li Y, Nie Y, Helou Y, Ding G, Feng B, Xu G . Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation. Diabetes. 2013; 62(7):2396-409. PMC: 3712026. DOI: 10.2337/db12-1081. View

Meyer M, Mahr A, Brewer J, Daniel V, DellAringa J, Goldstone T . A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics. Nat Rev Drug Discov. 2023; 23(1):1-2. DOI: 10.1038/d41573-023-00189-4. View

Baselli G, Jamialahmadi O, Pelusi S, Ciociola E, Malvestiti F, Saracino M . Rare ATG7 genetic variants predispose patients to severe fatty liver disease. J Hepatol. 2022; 77(3):596-606. DOI: 10.1016/j.jhep.2022.03.031. View

10.

Do A, Zahrawi F, Mehal W . Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nat Rev Drug Discov. 2024; 24(3):171-189. DOI: 10.1038/s41573-024-01084-2. View